{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:40:04Z","timestamp":1769604004335,"version":"3.49.0"},"reference-count":17,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["J1103606"],"award-info":[{"award-number":["J1103606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The epidermal growth factor receptors (EGFRs), in which overexpression (known as upregulation) or overactivity have been associated with a number of cancers, has become an attractive molecular target for the treatment of selective cancers. We report here the design and synthesis of a novel series of 4,5-dihydro-1H-thieno [2\u2032,3\u2032:2,3]thiepino[4,5-c]pyrazole-3-carboxamide derivatives and the screening for their inhibitory activity on the EGFR high-expressing human A549 cell line using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). A Docking simulation was performed to fit compound 6g and gifitinib into the EGFR to determine the probable binding models, and the binding sites and modes conformation of 6g and gifitinib were exactly similar, the two compounds were stabilized by hydrogen bond interactions with MET769. Combining with the biological activity evaluation, compound 6g demonstrated the most potent inhibitory activity (IC50 = 9.68 \u00b1 1.95 \u03bcmol\u00b7L\u20131 for A549). Conclusively, 4,5-dihydro-1H-thieno[2\u2032,3\u2032:2,3]thiepino[4,5-c]pyrazole-3-carboxamide derivatives as the EGFR tyrosine kinase inhibitors were discovered, and could be used as potential lead compounds against cancer cells.<\/jats:p>","DOI":"10.3390\/molecules23081980","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T03:33:48Z","timestamp":1533785628000},"page":"1980","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Discovery of 4,5-Dihydro-1H-thieno[2\u2032,3\u2032:2,3]thiepino [4,5-c]pyrazole-3-carboxamide Derivatives as the Potential Epidermal Growth Factor Receptors for Tyrosine Kinase Inhibitors"],"prefix":"10.3390","volume":"23","author":[{"given":"Jia","family":"Ke","sequence":"first","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Lu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Jin","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Zhan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1384-7465","authenticated-orcid":false,"given":"Jianshu","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Chi-cheong","family":"Wan","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-2870","authenticated-orcid":false,"given":"Chun","family":"Hu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1021\/jm0608762","article-title":"Multitarget-directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects","volume":"49","author":"Antonello","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_2","first-page":"5536","article-title":"Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors","volume":"55","author":"Moscatello","year":"1995","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor-related peptides and their receptors in human malignancies","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI32278","article-title":"ErbB receptors: From oncogenes to targeted cancer therapies","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1023726827771","article-title":"Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets","volume":"22","author":"Barnes","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/B:JCAM.0000004622.13865.4f","article-title":"3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors","volume":"17","author":"Assefa","year":"2003","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases\u2014The major drug targets of the twenty-first century?","volume":"1","author":"Cohen","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12022","DOI":"10.1073\/pnas.95.20.12022","article-title":"Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor","volume":"95","author":"Fry","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","first-page":"4838","article-title":"Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase","volume":"57","author":"Moyer","year":"1997","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20121513","article-title":"Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain","volume":"448","author":"Park","year":"2012","journal-title":"Biochem. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/jo00236a003","article-title":"Utilization of \u03b1, \u03b2-unsaturated acids as Michael acceptors for the synthesis of thieno[2,3-b]thiopyrans","volume":"53","author":"Ponticello","year":"1988","journal-title":"J. Org. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/jhet.5570270504","article-title":"Synthesis of isochroman-fused pyrazolone and pyrimidine derivatives","volume":"27","author":"Wang","year":"1990","journal-title":"J. Heterocycl. Chem."},{"key":"ref_13","first-page":"113","article-title":"Synthesis of isochromano[4,3-C]pyrazole substituted with biheterocycle at 3-position","volume":"15","author":"Zhao","year":"2002","journal-title":"J. Yantai Univ. Nat. Sci. Eng. Ed."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1541-7786.MCR-15-0480","article-title":"Reciprocal negative regulation between EGFR and DEPTOR plays an important role in the progression of lung adenocarcinoma","volume":"14","author":"Zhou","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1517\/17425247.2014.930433","article-title":"Cytotoxic enhancement of hexapeptide-conjugated micelles in EGFR high-expressed cancer cells","volume":"11","author":"Lin","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Liu, D., Luan, T., Kong, J., Zhang, Y., and Wang, H.F. (2016). Synthesis and anti-tumor activities of 4-anilinoquinoline derivatives. Molecules, 21.","DOI":"10.3390\/molecules21010021"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/8\/1980\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:17:23Z","timestamp":1760195843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/8\/1980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["molecules23081980"],"URL":"https:\/\/doi.org\/10.3390\/molecules23081980","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]}}}